TCL Archive DCT Board Approves Concepts Of Eight New Biological Response Modifiers Program July 3, 1981
TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013
TCL Archive SWOG Seeks NSCLC Patients For Study Of Gender Differences In Lung Cancer October 28, 2005
TCL Archive In Brief: Thomas King Names Special Assistant To Lombardi Center Director; John MacDonald Takes U. Ky. Job March 30, 1984